Halozyme Therapeutics (HALO)
110.19
-0.57 (0.51%)
Upcoming Events
Latest Headlines
H.C. Wainwright Reiterates Buy Rating on Halozyme Therapeutics (HALO)
September 3, 2026 6:58 AM - StreetInsider
Form 3 HALOZYME THERAPEUTICS, For: Aug 14 Filed by: Appelhans Dannielle
August 21, 2026 4:55 PM - SEC Filing
Form 4 HALOZYME THERAPEUTICS, For: Aug 17 Filed by: Torley Helen
August 19, 2026 8:01 PM - SEC Filing
Form 8-K HALOZYME THERAPEUTICS, For: Aug 14
August 18, 2026 4:04 PM - SEC Filing
Halozyme adds biotech executive Appelhans to its board
August 18, 2026 4:01 PM - StreetInsider
Halozyme Appoints Dannielle Appelhans to its Board of Directors
August 18, 2026 4:01 PM - PR NewsWire
H.C. Wainwright Reiterates Buy Rating on Halozyme Therapeutics (HALO)
August 18, 2026 6:38 AM - StreetInsider
Form 144 HALOZYME THERAPEUTICS, Filed by: Torley Helen
August 17, 2026 5:16 PM - SEC Filing
Form 144 HALOZYME THERAPEUTICS, Filed by: Caudill Cortney
August 11, 2026 5:58 PM - SEC Filing
Form 4 HALOZYME THERAPEUTICS, For: Aug 10 Filed by: Connaughton Bernadette
August 11, 2026 5:44 PM - SEC Filing
Form 144 HALOZYME THERAPEUTICS, Filed by: Connaughton Bernadette
August 10, 2026 4:34 PM - SEC Filing
Halozyme Therapeutics (HALO) PT Raised to $105 at TD Cowen
August 7, 2026 8:52 AM - StreetInsider
Halozyme Therapeutics (HALO) PT Raised to $95 at Wells Fargo
August 7, 2026 8:19 AM - StreetInsider
Halozyme Therapeutics (HALO) PT Raised to $93 at Citizens on Royalty Revenue Growth
August 7, 2026 7:32 AM - StreetInsider
Leerink Upgrades Halozyme Therapeutics (HALO) to Outperform
August 7, 2026 7:02 AM - StreetInsider
Halozyme Therapeutics (HALO) Tops Q2 EPS by 47c; raises guidance
August 6, 2026 4:30 PM - StreetInsider
Form 10-Q HALOZYME THERAPEUTICS, For: Jun 30
August 6, 2026 4:16 PM - SEC Filing
Form 8-K HALOZYME THERAPEUTICS, For: Aug 06
August 6, 2026 4:12 PM - SEC Filing
HALOZYME REPORTS RECORD SECOND QUARTER 2026 RESULTS, BEATS ESTIMATES AND RAISES FULL YEAR 2026 FINANCIAL GUIDANCE
August 6, 2026 4:01 PM - PR NewsWire
Halozyme to Report Second Quarter 2026 Financial and Operating Results
July 23, 2026 8:30 AM - PR NewsWire
Benchmark Reiterates Buy Rating on Halozyme Therapeutics (HALO) on 'Solid Partnership Momentum'
July 21, 2026 9:23 AM - StreetInsider
Halozyme and Incyte sign drug delivery licensing agreement
July 20, 2026 8:00 AM - StreetInsider
Halozyme Announces Global Collaboration and License Agreement with Incyte to Support the Development of Subcutaneous Formulations of INCA033989 Using its ENHANZE® Technology
July 20, 2026 8:00 AM - PR NewsWire
Russell Investments Canada Limited Announces Monthly Distributions for Exchange Traded Fund Series (“ETF Series”) and Exchange Traded Funds (“ETFs”)
July 14, 2026 4:00 PM - BizWire
Form 4 HALOZYME THERAPEUTICS, For: Jul 08 Filed by: Torley Helen
July 9, 2026 5:20 PM - SEC Filing
Form 4 HALOZYME THERAPEUTICS, For: Jun 30 Filed by: RAMSAY DAVID A
July 2, 2026 4:46 PM - SEC Filing
Form 4 HALOZYME THERAPEUTICS, For: Jul 01 Filed by: Snellgrove Darren
July 2, 2026 4:44 PM - SEC Filing
Form 4 HALOZYME THERAPEUTICS, For: Jul 01 Filed by: Connaughton Bernadette
July 2, 2026 4:42 PM - SEC Filing
Form 8-K HALOZYME THERAPEUTICS, For: Jun 30
July 2, 2026 4:10 PM - SEC Filing
Form 4 HALOZYME THERAPEUTICS, For: Jun 29 Filed by: Krishnan Mahesh
June 30, 2026 5:25 PM - SEC Filing
Halozyme names David Ramsay as president of drug delivery
June 30, 2026 4:02 PM - StreetInsider
Halozyme Appoints David Ramsay as President Drug Delivery
June 30, 2026 4:02 PM - PR NewsWire
Form 144 HALOZYME THERAPEUTICS, Filed by: Krishnan Mahesh
June 29, 2026 4:41 PM - SEC Filing
H.C. Wainwright Reiterates Buy Rating on Halozyme Therapeutics (HALO)
June 16, 2026 6:43 AM - StreetInsider
Form 4 HALOZYME THERAPEUTICS, For: Jun 12 Filed by: Snyder Mark Howard
June 15, 2026 4:10 PM - SEC Filing
Halozyme expects minimal Medicare pricing impact on royalties through 2035
June 15, 2026 6:01 AM - StreetInsider
Halozyme Confirms It Projects Zero to Minimal Impact to Royalty Revenue Through At Least 2035 Based on Newly Released Draft Medicare Drug Price Negotiation Program Proposed Rule for IPAY 2029
June 15, 2026 6:00 AM - PR NewsWire
Form 3 HALOZYME THERAPEUTICS, For: Jun 08 Filed by: Snellgrove Darren
June 9, 2026 4:59 PM - SEC Filing
Full Article List
